Meadow Creek Wealth Advisors LLC Bristol Myers Squibb CO Transaction History
Meadow Creek Wealth Advisors LLC
- $137 Million
- Q4 2024
A detailed history of Meadow Creek Wealth Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Meadow Creek Wealth Advisors LLC holds 8,482 shares of BMY stock, worth $457,179. This represents 0.35% of its overall portfolio holdings.
Number of Shares
8,482
Previous 5,945
42.67%
Holding current value
$457,179
Previous $307,000
56.03%
% of portfolio
0.35%
Previous 0.25%
Shares
7 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...